Skip to main content Accessibility help
×
Home

Re-evaluating carbamazepine prophylaxis in bipolar disorder

  • Robert M. Post (a1), Kirk D. Denicoff (a1), Mark A. Frye (a1) and Gabriele S. Leverich (a1)
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Re-evaluating carbamazepine prophylaxis in bipolar disorder
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Re-evaluating carbamazepine prophylaxis in bipolar disorder
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Re-evaluating carbamazepine prophylaxis in bipolar disorder
      Available formats
      ×

Abstract

  • An abstract is not available for this content so a preview has been provided below. To view the full text please use the links above to select your preferred format.

Copyright

Corresponding author

Dr Robert M. Post, Chief, Biological Psychiatry Branch, NIMH, Building 10, Room 3N212, 10 Center Drive, MSC 1272, Bethesda, MD 20892-1272, USA

References

Hide All
Ballenger, J. C. & Post, R. M. (1978) Therapeutic effects of carbamazepine in affective illness: A preliminary report. Communications in Psychopharmacology. 2, 159175.
Bellaire, W., Demisch, K. & Stoll, K.-D. (1990) Carbamazepine vs. lithium. Application m the prophylaxis of recurrent affective and schizoaffective psychoses. Munch Med Wschr. 132. S82S86.
Bowden, C. L., Brugger, A. M., Swann, A. C., et al (1994) Efficacy of divalproex vs lithium and placebo in the treatment of mania. Journol of the American Medical Association. 271, 918924.
Calabrese, J. R., Woyshville, M. J., Kimmel, S. E., et al (1993) Predictors of valproate response m bipolar rapid cycling. Journal of Clinical Psychopharmacology, 13, 280283.
Cabera, J. F., Muhlbauar, H. D., Schley, J., et al (1986) Long-term randomized clinical trial on oxcarbazepme vs. lithium in bipolar and schizoaffective disorders: preliminary results. Pharmacopsychiatry 19, 282283.
Dardennes, R., Even, C., Bange, F., et al (1995) Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders. A meta-analysis. British Journal of Psychiatry. 166. 378 381.
Denicoff, K. D., Blalce, K. D., Smith-Jackson, E. E., et al (1994) Morbidity in treated bipolar disorder: a one-year prospective study using daily life chart ratings. Depression. 2. 95 104.
Di Cosunzo, E. & Schifano, F. (1991) Lithiunrt alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder Acta Psychiotnca Scandinavica. 83. 456459.
Elphick, M., Lyons, F. & Cowen, P. J. (1988) Low tolerability of carbamazepine in psychiatric patients may restrict its clinical usefulness. Journal of Psychopharmacology. 2, 14.
Emrich, H. M., Von Zerssen, D., Kissling, W., et al (1980) Effect of sodium valproate m mama. The GABA hypothesis of affective disorders. Arch Psychiatr Nervenkr, 229, 116.
Grof, P. (1994) Designing long-term clinical trials in affective disorders. Journol of Affective Disorders. 30, 243255.
Hirschfeld, R. M. A., Clayton, R. Cohen, I., et al (1994) American Psychiatric Association practice guidelines for bipolar disorder. American Journal of Psychiatry. 151 (suppl.), 136.
Jacobsen, F. M. (1993) Low-dose valproate; A new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome, journal of Clinical Psychiatry. 54, 229234.
Ketter, T. A., Kimbrell, T. A., George, M. S., et al (1996) Baseline hypermetabolism may predict carbamazepine response, and hypometabolism nimodipine response m mood disorders. Abstracts of the 20th CINP Congress. 10 (abstract 0–5–6).
Kishimoto, A. & Okuma, T. (1986) Antimamc and prophylactic effects of carbamazepine in affective disorders. In Biological Psychiatry (eds Shagas, C. Josiassen, R. C., Bridger, W. H. et al). pp. 883885. Amsterdam: Elsevier.
Lambert, P. A. (1984) Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide). In Anticonvulsants in Affective Disorders (eds Emnch, H. M. Okuma, T. & Muller, A. A.), pp. 3344, Amsterdam: Exerpta Medica.
Lusznat, R. M., Murphy, D. R A. Nunn, C. M. H. (1988) Carbamazepine vs. lithium in the treatment and prophylaxis of mama. British Journal of Psychiatry 153, 198204.
McElroy, S. L., Keck, P. E., Pope, H. G., et al (1992) Valproate m the treatment of bipolar disorder: Literature review and clinical guidelines. Journal of Clinical Psychopharmacology 12 (suppl. I), 42S52S.
Mosolov, S. N. (1991) Comparative effectiveness of preventive use of lithium carbonate, carbamazepine and sodium valproate in affective and schizoaffective psychoses. Zhurnal Nevropatologii I Psikhiatni Imeni S S. Korsakova (Moskva). 91, 7883.
Murphy, D. J., Gannon, M. A. & McGennis, A. (1989) Carbamazepine in bipolar affective disorder (letter). Lancet. ii 1151 1152.
O'Connell, R. A., Major, J. A., Flattew, L., et al (1991) Outcome of bipolar disorder on long-term treatment with lithium. British Journal of Psychiatry 159, 123129.
Okuma, T., Inanaga, K., Otsuke, S., et al (1981) A preliminary double-blind study of the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology 73, 9596.
Pellock, J. M. (1987) Carbamazepine side effects in children and adults. Epilepsia. 28 (suppl. 3), S64S70.
Placidi, G. F., Lenzi, A., Lazzerini, F., et al (1986) The comparative efficacy and safety of carbamazepine versus lithium: A randomized, double-blind 3-year trial in 83 patients. Journal of Clinical Psychiatry 47, 490494.
Post, R. M., Uhde, T. W., Ballenger, J. C., et al (1983) Prophylactic efficacy of carbamazepine in manic-depressive illness. American Journal of Psychiatry 140, 16021604.
Post, R. M., Ballenger, J. C., Berrettlni, W. H., Uhde, T. W., et al (1984) Selective response to the anticonvulsant carbamazepine in manic-depressive illness: A case study Journal of Clinical Psychopharmacology 4, 178185.
Post, R. M., Ballenger, J. C., Berrettlni, W. H., Uhde, T. W., Leverich, G. S., Rosoff, A. S., et al (1990) Carbamazepine prophylaxis in refractory affective disorders: A focus on long-term follow-up. Journol of Clinical Psychopharmacology 10, 318327.
Post, R. M., Ballenger, J. C., Berrettlni, W. H., Uhde, T. W., Leverich, G. S., Rosoff, A. S., Ketter, T. A., Pazzaglla, P. J., et al (1996) Rational polypharmacy in the bipolar affective disorders. Epilepsy Research, in press.
Prien, R. F. & Gelenberg, A. J. (1989) Alternatives to lithium for preventive treatment of bipolar disorder. American Journal of Psychiatry 146, 840848.
Schaff, M. R., Fawcett, J. & Zajecka, J. M. (1993) Divalproex sodium in the treatment of refractory affective disorders. Journal of Clinical Psychiatry 54, 380384.
Svetska, J., Nahunek, K., Ceskova, E., et al (1985) Carbamazepine prophylaxis of affective psychoses (intraindividual comparison with lithium carbonate). Activ Nerv Sup. 27, 261262.
Vestergaard, P. (1992) Treatment and prevention of mama: A Scandinavian perspective. Neuropsychopharmacology 7, 249260.
Watkins, S. E., Callender, K., Thomas, D. R., et al (1987) The effect of carbamazepine and lithium on remission from affective illness. British Journal of Psychiatry 150, 180182.

Re-evaluating carbamazepine prophylaxis in bipolar disorder

  • Robert M. Post (a1), Kirk D. Denicoff (a1), Mark A. Frye (a1) and Gabriele S. Leverich (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Re-evaluating carbamazepine prophylaxis in bipolar disorder

  • Robert M. Post (a1), Kirk D. Denicoff (a1), Mark A. Frye (a1) and Gabriele S. Leverich (a1)
Submit a response

eLetters

We encountered an error trying to retrieve eLetters for this article. Please try again or contact Customer Services

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *